drug candidate
| 4 min read
Ignota Labs is using artificial intelligence to revive shelved drug candidates, reduce clinical risk, and cut carbon emissions.
| 4 min read
New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects.
Page 1 of 1 - 2 Total Items
